Title Phenotype Institution Algorithm Type Total Casessort descending Total Controls PPV Sensitivity
Intellectual disability Adult population Intellectual Disability Vanderbilt Case, Control 25 6,231
Marshfield Hearing loss validation Hearing Loss Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 1.00
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 1.00, 1.00
Geisinger caMRSA Implementation caMRSA Geisinger Case, Control 25 25 0.96, 1.00 0.96
Group Health and UW Zoster Implementation Herpes Zoster Group Health and UW Case, Control 25 25 1.00, 0.96 1.00
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 0.92, 1.00 1.00, 1.00
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 0.96
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 1.00, 0.96
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 1.00, 1.00
Geisinger Zoster Implementation Herpes Zoster Geisinger Case, Control 27 27 0.89, 0.96 1.00
Emerge III Implementation Appendicitis Geisinger Case, Control 30 13,032
NU appendicitis cases Appendicitis Northwestern University Case Only 30 1.00
Columbia - Migraine Migraine Columbia University Medical Center Case, Control 37 2,294
Migraine--Columbia Migraine Columbia University Case, Control 37 2,294
Statin and MACE Implementation - Columbia Statins and MACE Columbia University Case, Control 41 570
Northwestern Univ. CAAD CAAD (Carotid Artery Atherosclerosis Disease) Northwestern University Case, Control 44 461
Hypothyroidism Implementation - Columbia Hypothyroidism Columbia University Case, Control 45 129
Harvard CDiff Clostridium Difficile Colitis Harvard Medical School Case Only 47 1,643
Nortwestern University e3 Implementation CAAD (Carotid Artery Atherosclerosis Disease) Northwestern University Case, Control 48 133
Marshfield Venous Thromboembolism implementation Venous Thromboembolism (VTE) Marshfield Clinic Research Foundation Case, Control 50 49 0.98, 1.00
Autism Validation Autism CHOP Case Only 50 0.85 0.74
AMI/1st AMI Vanderbilt Implementation Statins and MACE Vanderbilt University Case Only 50 0.96
Statins and MACE Marshfield Implementation Statins and MACE Marshfield Clinic Research Foundation Case Only 50 1.00 1.00
Northwestern University Validation Colorectal Cancer (CRC) Northwestern University Case, Control 50 50 0.86, 0.98 0.92
Marshfield diverticulosis/diverticulitis implementation Diverticulosis and Diverticulitis Marshfield Clinic Research Foundation Case, Control 50 50 1.00, 1.00

Pages